Michelle Melanson
About Michelle Melanson
Michelle Melanson is a Senior Research Associate specializing in translational pharmacology at the Broad Institute of MIT and Harvard, where she has worked since 2016. She has a background in biochemistry and fine arts, with experience in cell-based assay development and high-throughput screening techniques.
Work at Broad
Michelle Melanson has been employed at the Broad Institute of MIT and Harvard since 2016. In her role as Senior Research Associate in Translational Pharmacology at the Center for the Development of Therapeutics, she focuses on advancing drug discovery processes. Her responsibilities include developing and optimizing cell-based assays and implementing high-throughput screening techniques to facilitate research initiatives.
Education and Expertise
Michelle Melanson holds a Bachelor of Fine Arts (BFA) from the Massachusetts College of Art. Additionally, she earned a Bachelor of Science (B.S.) in Biochemistry from the University of Massachusetts Boston. Her educational background supports her expertise in high-content screening and cell-based assay development, which are critical in the field of translational pharmacology.
Background
Prior to her current position, Michelle Melanson worked at Horizon Discovery as a Research Associate II from 2014 to 2016, where she contributed to various research projects in Cambridge, MA. She also held the position of Compound Management Associate at Zalicus Incorporated from 2013 to 2014, further enhancing her experience in the biotechnology sector.
Professional Networking and Research Opportunities
Michelle actively seeks to expand her professional network and explore new research opportunities. This proactive approach allows her to stay informed about advancements in her field and collaborate with other professionals, which can lead to innovative research initiatives and partnerships.
Specialization in High-Throughput Screening
Michelle Melanson specializes in cell-based assay development and high-throughput screening techniques. Her expertise spans various therapeutic indications, enabling her to contribute effectively to drug discovery efforts and enhance the understanding of potential therapeutic targets.